Draganfly Selected to Develop Tactical Multi-Drop Payload System by MMS Products
Tampa, FL., Jan. 30, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]
Aduro Clean Technologies Engages Crystal Research Associates to Provide Marketing and Investor Relations Services
LONDON, Ontario, Jan. 30, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) […]
LEEF Brands Inc. Announces Strategic Partnership with AG Advisors LLC for Cultivation Management Services
VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — LEEF Brands, Inc. (“LEEF” or the “Company”) (CSE: LEEF, OTC: LEEEF), […]
Malibu Boats, Inc. Announces Second Quarter Fiscal 2024 Results
LOUDON, Tenn., Jan. 30, 2024 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the […]
Breckenridge Distillery and Breckenridge Brewery Announce Fourth Edition of Sexy Motor Oil Whiskey and New Sexy Motor Oil Beer
BRECKENRIDGE, Colo., Jan. 30, 2024 (GLOBE NEWSWIRE) — Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and Breckenridge […]
Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
– No differentiation syndrome events reported – – 100% CR rate with 7+3 in newly diagnosed NPM1-m and KMT2A-r AML […]
Kaixin Auto Holdings Announces Export Intention Order of 1,000 EVs
BEIJING, Jan. 30, 2024 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN), a leading new energy […]
TSX News -
Descartes’ Study Reveals 76% of Supply Chain and Logistics Operations are Experiencing Notable Workforce Shortages
Transportation & Warehouse Operations Most Challenged by Resource Shortages ATLANTA, Georgia and LONDON, U.K., Jan. 30, 2024 (GLOBE NEWSWIRE) — […]
Unitil Schedules Fourth Quarter 2023 Earnings Release and Conference Call
HAMPTON, N.H., Jan. 30, 2024 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its fourth […]
Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study
FLORHAM PARK, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused […]
